Internal Medicine, Cardiovascular Disease · Portsmouth, OH
NPI
1427203652
Since 2008
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1711 27th St Ste 206
Portsmouth, OH, 45662
Phone (740) 356-8772
Groups this clinician bills Medicare through
Medicare paid, 2024
$318K
6,305 services
Medicare patients, 2024
1,623
Average age 75
Drug cost, 2024
$1.4M
9,439 prescriptions
Company payments, 2025
$92.27
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tarun R Nagrani was code 93010 (electrocardiogram), 1,366 times for 820 patients. In total Tarun R Nagrani billed 6,305 services in 79 codes, and Medicare paid $318K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-04-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93010 Electrocardiogram | Facility | 1,366 | 820 | $5.79 | $7,916 |
| 99213 Office E&M - Established | Facility | 761 | 624 | $45.94 | $35K |
| 99214 Office E&M - Established | Facility | 518 | 382 | $70.48 | $37K |
| 93298 External Electrocardiographic Monitoring | Facility | 458 | 65 | $21.66 | $9,922 |
| 93297 External Electrocardiographic Monitoring | Facility | 360 | 43 | $19.44 | $7,000 |
| 93294 External Electrocardiographic Monitoring | Facility | 354 | 109 | $20.96 | $7,419 |
| 99152 Anesthesia | Facility | 324 | 296 | $9.23 | $2,989 |
| 93306 Echocardiography (TTE/TEE) | Facility | 299 | 297 | $50.15 | $15K |
| 93458 Percutaneous Transcatheterization | Facility | 219 | 214 | $170.39 | $37K |
| 93571 Percutaneous Transcatheterization | Facility | 141 | 136 | $32.07 | $4,522 |
| 92928 Percutaneous Coronary Artery Angioplasty and Stenting | Facility | 140 | 115 | $399.78 | $56K |
| 92978 Echocardiography (TTE/TEE) | Facility | 139 | 131 | $70.48 | $9,797 |
| 99223 Hospital E&M - Initial | Facility | 120 | 112 | $131.14 | $16K |
| 93280 External Electrocardiographic Monitoring | Facility | 116 | 97 | $25.01 | $2,901 |
| 93295 External Electrocardiographic Monitoring | Facility | 93 | 28 | $27.23 | $2,532 |
By year: 2022 $308K for 6,373 services; 2023 $307K for 6,231 services; 2024 $318K for 6,305 services.
Medicare prescription drug claims, 2024
In 2024, the drug Tarun R Nagrani prescribed most often to Medicare patients was Atorvastatin Calcium, with 943 prescriptions and refills. In total Tarun R Nagrani wrote 9,439 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 943 | 2,372 | 338 | $7,531 |
| Metoprolol Succinate Generic | 937 | 2,201 | 315 | $14K |
| Carvedilol Generic | 671 | 1,612 | 240 | $4,391 |
| Amlodipine Besylate Generic | 589 | 1,417 | 214 | $3,126 |
| Furosemide Generic | 588 | 1,352 | 221 | $2,725 |
| Potassium Chloride Generic | 476 | 1,045 | 164 | $7,894 |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 426 | 963 | 137 | $4,193 |
| Clopidogrel Clopidogrel Bisulfate | 377 | 907 | 139 | $3,896 |
| Lisinopril Generic | 357 | 852 | 139 | $2,036 |
| Eliquis Apixaban | 351 | 726 | 99 | $414K |
| Xarelto Rivaroxaban | 351 | 756 | 102 | $404K |
| Prasugrel Hcl Generic | 336 | 793 | 124 | $46K |
| Nifedipine Er Nifedipine | 322 | 787 | 126 | $8,165 |
| Ranolazine Er Ranolazine | 285 | 638 | 91 | $21K |
| Losartan Potassium Generic | 254 | 584 | 89 | $1,863 |
Brand drugs: 1,176 claims; generic drugs: 8,263 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tarun R Nagrani $92.27 ($92.27 in general payments such as food, travel and fees) from 2 companies. The largest payer was Abbott Laboratories with $70.01.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 4 | $70.01 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $22.26 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.